Literature DB >> 10513103

Toward improving the reliability of clinical acupuncture trials: arguments against the validity of "sham acupuncture" as controls.

D Ryan1.   

Abstract

In refining the design of single-blind acupuncture research trials, "sham acupuncture" has been proposed and used in trials as a useful "inactive" control, yet the degree of inactivity with sham acupuncture points remains largely undetermined. With neural and dermal effects occurring whenever a needle is inserted into the skin, regardless of depth or location, the estimated effect upon Qi when needling sham acupuncture points remains a matter of conjecture. This paper examines the statistical consequences of utilizing sham acupuncture as a control when its energetic and biomedical effects are unknown. It argues the need for a more careful consideration of "assumptions" in clinical research design.

Mesh:

Year:  1999        PMID: 10513103

Source DB:  PubMed          Journal:  Am J Acupunct        ISSN: 0091-3960


  3 in total

1.  Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology. Interim results of a multicenter crossover study.

Authors:  Tobias K Reindl; Wilhelm Geilen; Reinhard Hartmann; Klaus R Wiebelitz; Guishi Kan; Ilca Wilhelm; Siegfried Lugauer; Clemens Behrens; Thomas Weiberlenn; Carola Hasan; Sven Gottschling; Tanja Wild-Bergner; Guenter Henze; Pablo Hernáiz Driever
Journal:  Support Care Cancer       Date:  2005-07-14       Impact factor: 3.603

2.  Acupuncture at "Zusanli" (St.36) and "Sanyinjiao" (SP.6) Points on the Gastrointestinal Tract: A Study of the Bioavailability of (99m)Tc-Sodium Pertechnetate in Rats.

Authors:  Vasco Senna-Fernandes; Daisy L M França; Deise de Souza; Kelly C M Santos; Rafael S Sousa; Cristiano V Manoel; Sebastião D Santos-Filho; Célia M Cortez; Mario Bernardo-Filho; Marco Antonio M Guimarães
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-18       Impact factor: 2.629

3.  Acupuncture de qi in stable somatosensory stroke patients: relations with effective brain network for motor recovery.

Authors:  Lijun Bai; Fangyuan Cui; Yihuai Zou; Lixing Lao
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-02       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.